Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Role, Safety Oversight Addressed In Health IT Framework Comments

This article was originally published in The Gray Sheet

Executive Summary

Debate over the appropriate system for regulating health IT tools continued in written comments recently submitted to HHS.


Related Content

Pending Mobile Medical Apps Guidance Provokes Heated Controversy
Workgroup Unveils Preliminary Health IT Regulation Proposals
Draft Bill Aims To Clarify FDA Regulation Of Mobile Medical Apps
Rep. Honda Reintroduces Bill To Create FDA Office Of Wireless Health





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts